Skip to main content
. Author manuscript; available in PMC: 2021 May 7.
Published in final edited form as: Ann Intern Med. 2015 Sep 15;163(6):417–426. doi: 10.7326/M14-1804

Table 1.

Base-Case Model Parameters

Parameter CRT-D ICD References
Patient age, y 65 65 11, 12
Device implantation, %
 Procedural success 94 100 13
 Implant complication* 5 3 24
 Procedural death 0.3 0.2 24
Efficacy
 Mortality (risk ratio, CRT-D vs. ICD) 0.80 - 13
 Hospitalization (risk ratio, CRT-D vs. ICD) 0.69 - 12, 13
Mortality
 Baseline riskfor cardiac death 0.0037 0.0037 12
Device complications
 Lead failure 0.0022 0.0015 25
 Lead infection 0.0007 0.0007 25–28
 Death from lead failure 0.013 0.013 29
 Death from lead infection 0.05 0.05 27, 30
 Length of lead failure hospitalization, d 2 2 Expert opinion
 Length of lead infection hospitalization, d 5 5 CMS
 Battery life, y 4 5 31
Heart failure events
 Baseline hospitalization 0.006 0.008 11, 12
 Subsequent hospitalization 0.06 0.06 23
 Death afterheart failure hospitalization 0.05 0.05 23
 Length of heart failure hospitalization, d 5 5 CMS
Device costs, $
 Implantation without complication 40 892 33 323 CMS
 Implantation with complication 49 418 41 850 CMS
 Failed CRT-D implantation 33 892 - CMS
 Lead failure 16 425 16 361 CMS
 Lead infection 49 149 40 812 CMS
 Generator change 34 902 27 884 CMS
Heart failure costs, $
 Heart failure hospitalization 6227 6227 CMS
 Heart failure background costs 1298/mo 1298/mo CMS, 32, 33
Utilities
 Baseline 0.884 0.874 15
 Decrement for age75yorolder Baseline × 0.931 Baseline × 0.931 34
 Decrement forheart failure hospitalization Baseline × 0.828for7 d§, followed by 0 for 5 d Baseline × 0.828 for 7 d§, followed by 0 for 5 d 19, 35
 Decrement for lead failure 0 for 2 d 0 for 2 d 19
 Decrement for lead infection 0 for 5 d 0 for 5 d 19

CMS = Centers for Medicare & Medicaid Services;CRT-D = cardiac resynchronization therapy combined with an implantable cardioverter-defibrillator; ICD = implantable cardioverter-defibrillator.

*

Defined as pneumothorax, hematoma, and complications related to the coronary sinus.

Corresponding to a derived risk ratio (applied to cardiac death only) of 0.69.

Indicates unit in monthly probability terms.

§

Corresponding to a drop to New York Heart Association class III symptoms.